Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Genetic, biochemical, and clinical features of LCAT deficiency: update for 2020
Chiara Pavanello, Laura Calabresi
Current Opinion in Lipidology (2020) Vol. 31, Iss. 4, pp. 232-237
Closed Access | Times Cited: 44

Showing 1-25 of 44 citing articles:

Metabolic-associated fatty liver disease and lipoprotein metabolism
Jöerg Heeren, Ludger Scheja
Molecular Metabolism (2021) Vol. 50, pp. 101238-101238
Open Access | Times Cited: 403
A Modern Approach to Dyslipidemia
Amanda J. Berberich, Robert A. Hegele
Endocrine Reviews (2021) Vol. 43, Iss. 4, pp. 611-653
Open Access | Times Cited: 287
Standardising lipid testing and reporting in the United Kingdom; a joint statement by HEART UK and The Association for Laboratory Medicine
Julia Kenkre, Tina Mazaheri, R. Dermot G. Neely, et al.
Annals of Clinical Biochemistry International Journal of Laboratory Medicine (2025)
Closed Access | Times Cited: 1
LCAT- targeted therapies: Progress, failures and future
Kaixu Yang, Junmin Wang, Hongjiao Xiang, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 147, pp. 112677-112677
Open Access | Times Cited: 32
HDL and chronic kidney disease
Chiara Pavanello, Alice Ossoli
Atherosclerosis Plus (2023) Vol. 52, pp. 9-17
Open Access | Times Cited: 12
The vicious circle of chronic kidney disease and hypertriglyceridemia: what is first, the hen or the egg?
Thiago Medeiros da Costa Daniele, Laura De Marchis, Larouche Miriam, et al.
Atherosclerosis (2025) Vol. 403, pp. 119146-119146
Open Access
HDL-Replacement Therapy: From Traditional to Emerging Clinical Applications
Cesare R. Sirtori, Giulia Cincotto, Sofia Castiglione, et al.
Atherosclerosis Plus (2025) Vol. 59, pp. 68-79
Open Access
High-Density Lipoproteins and the Kidney
Arianna Strazzella, Alice Ossoli, Laura Calabresi
Cells (2021) Vol. 10, Iss. 4, pp. 764-764
Open Access | Times Cited: 26
Acyl-Coenzyme A: Cholesterol Acyltransferase (ACAT) in Cholesterol Metabolism: From Its Discovery to Clinical Trials and the Genomics Era
Qimin Hai, Jonathan D. Smith
Metabolites (2021) Vol. 11, Iss. 8, pp. 543-543
Open Access | Times Cited: 26
Plasma and cerebrospinal fluid cholesterol esterification is hampered in Alzheimer’s disease
Marta Turri, Elisa Conti, Chiara Pavanello, et al.
Alzheimer s Research & Therapy (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 10
LCAT deficiency: a systematic review with the clinical and genetic description of Mexican kindred
Roopa Mehta, Daniel Elías-López, Alexandro J. Martagón, et al.
Lipids in Health and Disease (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 20
Recombinant human lecithin-cholesterol acyltransferase in patients with atherosclerosis: phase 2a primary results and phase 2b design
Marc P. Bonaca, Richard T. De George, David A. Morrow, et al.
European Heart Journal - Cardiovascular Pharmacotherapy (2021) Vol. 8, Iss. 3, pp. 243-252
Open Access | Times Cited: 19
The HDL mimetic CER‐001 remodels plasma lipoproteins and reduces kidney lipid deposits in inherited lecithin:cholesterol acyltransferase deficiency
Chiara Pavanello, Marta Turri, Arianna Strazzella, et al.
Journal of Internal Medicine (2021) Vol. 291, Iss. 3, pp. 364-370
Open Access | Times Cited: 17
Transitional Medicine of Intractable Primary Dyslipidemias in Japan
Masatsune Ogura, Sachiko Okazaki, Hiroaki Okazaki, et al.
Journal of Atherosclerosis and Thrombosis (2024) Vol. 31, Iss. 5, pp. 501-519
Open Access | Times Cited: 2
A decreased level of high‐density lipoprotein is a possible risk factor for type 2 diabetes mellitus: A review
Ali Bayat Bodaghi, Erfan Ebadi, Mohammad Javad Gholami, et al.
Health Science Reports (2023) Vol. 6, Iss. 12
Open Access | Times Cited: 5
Genetic Lipid Disorders Associated with Atherosclerotic Cardiovascular Disease
Reed Mszar, Gayley Webb, Vivek Kulkarni, et al.
Medical Clinics of North America (2022) Vol. 106, Iss. 2, pp. 325-348
Closed Access | Times Cited: 7
Reverse cholesterol transport and hepatic osteodystrophy
Mone Zaidi, Tony Yuen, Jameel Iqbal
Cell Metabolism (2022) Vol. 34, Iss. 3, pp. 347-349
Open Access | Times Cited: 7
The pleiotropic effects of high-density lipoproteins and apolipoprotein A-I
Shane R. Thomas, Yunjia Zhang, Kerry‐Anne Rye
Best Practice & Research Clinical Endocrinology & Metabolism (2022) Vol. 37, Iss. 3, pp. 101689-101689
Closed Access | Times Cited: 7
Novel therapeutic opportunities for familial lecithin:cholesterol acyltransferase deficiency: promises and challenges
Cecilia Vitali, Daniel J. Rader, Marina Cuchel
Current Opinion in Lipidology (2022) Vol. 34, Iss. 2, pp. 35-43
Closed Access | Times Cited: 7
High Density Lipoproteins: Is There a Comeback as a Therapeutic Target?
Arnold von Eckardstein
Handbook of experimental pharmacology (2021), pp. 157-200
Open Access | Times Cited: 9
Genetics and regulation of HDL metabolism
Dimitris Kardassis, Efstathia Thymiakou, Angeliki Chroni
Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids (2021) Vol. 1867, Iss. 1, pp. 159060-159060
Closed Access | Times Cited: 9
Plasma FA composition in familial LCAT deficiency indicates SOAT2-derived cholesteryl ester formation in humans
Chiara Pavanello, Alice Ossoli, Arianna Strazzella, et al.
Journal of Lipid Research (2022) Vol. 63, Iss. 7, pp. 100232-100232
Open Access | Times Cited: 6
Profoundly Disturbed Lipoproteins in Cirrhotic Patients: Role of Lipoprotein-Z, a Hepatotoxic LDL-like Lipoprotein
Eline H. van den Berg, Jose L. Flores‐Guerrero, Eke G. Gruppen, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 5, pp. 1223-1223
Open Access | Times Cited: 5
Apolipoprotein E isoforms differentially affect LCAT-dependent cholesterol esterification
Cecilia Vitali, Chiara Pavanello, Marta Turri, et al.
Atherosclerosis (2023) Vol. 382, pp. 117266-117266
Closed Access | Times Cited: 2
Genetically Engineered Hamster Models of Dyslipidemia and Atherosclerosis
Xunde Xian, Yuhui Wang, George E. Liu
Methods in molecular biology (2022), pp. 433-459
Closed Access | Times Cited: 3
Page 1 - Next Page

Scroll to top